Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 6,762,480 6.200% | 6,762,480 (New Position) | Filing History |
| 2023-11-09 1:26 pm Purchase | 2023-10-31 | 13G | Revolution Medicines, Inc. RVMD | Wellington Management Group LLP | 14,219,430 12.990% | 5,345,456 (+60.24%) | Filing History |
| 2023-06-30 4:33 pm Purchase | 2023-06-22 | 13G | Revolution Medicines, Inc. RVMD | BIOTECHNOLOGY VALUE FUND L P | 7,555,588 7.100% | 5,745,039 (+317.31%) | Filing History |
| 2023-06-16 4:12 pm Purchase | 2023-06-07 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital, LLC | 7,198,700 6.800% | 2,720,650 (+60.76%) | Filing History |
| 2023-02-14 4:15 pm Purchase | 2022-12-31 | 13G | Revolution Medicines, Inc. RVMD | BB BIOTECH AG | 4,777,562 5.400% | 175,000 (+3.80%) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Revolution Medicines, Inc. RVMD | Third Rock Ventures III L.P. | 1,939,692 2.200% | -3,713,598 (-65.69%) | Filing History |
| 2023-02-13 4:23 pm Unchanged | 2022-12-31 | 13G | Revolution Medicines, Inc. RVMD | COLUMN GROUP III LP | 3,347,199 3.800% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Revolution Medicines, Inc. RVMD | The Vanguard Group | 7,561,910 8.520% | 1,262,301 (+20.04%) | Filing History |
| 2023-02-06 2:56 pm Sale | 2022-12-30 | 13G | Revolution Medicines, Inc. RVMD | Wellington Management Group LLP | 8,873,974 9.990% | -62,495 (-0.70%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Revolution Medicines, Inc. RVMD | BlackRock Inc. BLK | 6,575,946 7.400% | 1,100,727 (+20.10%) | Filing History |
| 2023-01-23 12:14 pm Purchase | 2023-01-10 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital, LLC | 4,478,050 5.000% | 199,981 (+4.67%) | Filing History |
| 2022-12-09 1:50 pm Purchase | 2022-11-30 | 13G | Revolution Medicines, Inc. RVMD | Wellington Management Group LLP | 8,936,469 10.060% | 4,425,574 (+98.11%) | Filing History |
| 2022-09-29 7:49 pm Purchase | 2022-09-22 | 13G | Revolution Medicines, Inc. RVMD | BB BIOTECH AG | 4,602,562 5.200% | 4,602,562 (New Position) | Filing History |
| 2022-06-27 4:33 pm Purchase | 2022-06-16 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital, LLC | 4,278,069 5.800% | 4,278,069 (New Position) | Filing History |
| 2022-05-10 10:13 am Sale | 2022-05-09 | 13G | Revolution Medicines, Inc. RVMD | FMR LLC | 186,261 0.250% | -5,915,463 (-96.95%) | Filing History |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | Third Rock Ventures III L.P. | 5,653,290 7.700% | -3,295,779 (-36.83%) | Filing History |
| 2022-02-14 3:10 pm Sale | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | Cormorant Asset Management, LP | 2,431,852 3.300% | -1,243,148 (-33.83%) | Filing History |
| 2022-02-11 8:57 pm Sale | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | BIOTECHNOLOGY VALUE FUND L P | 1,810,549 2.500% | -1,946,500 (-51.81%) | Filing History |
| 2022-02-11 4:23 pm Sale | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | COLUMN GROUP III LP | 3,347,199 4.500% | -233,007 (-6.51%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | The Vanguard Group | 6,299,609 8.550% | 2,261,789 (+56.02%) | Filing History |